KEURIG DR PEPPER ($KDP) posted quarterly earnings results for Q4 2025 on Tuesday, February 24th. The company reported earnings of $0.60 per share, beating estimates of $0.59 by $0.01. The company also reported revenue of $4,499,000,000, beating estimates of $4,404,831,462 by $94,168,538.
You can see Quiver Quantitative's $KDP stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KEURIG DR PEPPER Insider Trading Activity
KEURIG DR PEPPER insiders have traded $KDP stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $KDP stock by insiders over the last 6 months:
- ANGELA A. STEPHENS (Senior VP & Controller) sold 10,000 shares for an estimated $295,200
- ERIC GORLI (President, US Refreshment Bev.) purchased 9,175 shares for an estimated $254,055
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
KEURIG DR PEPPER Hedge Fund Activity
We have seen 455 institutional investors add shares of KEURIG DR PEPPER stock to their portfolio, and 511 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 32,116,101 shares (+31.1%) to their portfolio in Q4 2025, for an estimated $899,571,989
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 30,835,166 shares (-74.9%) from their portfolio in Q4 2025, for an estimated $863,692,999
- HARRIS ASSOCIATES L P added 23,650,072 shares (+37.8%) to their portfolio in Q4 2025, for an estimated $662,438,516
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 18,698,262 shares (+inf%) to their portfolio in Q4 2025, for an estimated $523,738,318
- CAPITAL WORLD INVESTORS removed 16,305,980 shares (-14.2%) from their portfolio in Q4 2025, for an estimated $456,730,499
- CAPITAL INTERNATIONAL INVESTORS added 16,050,437 shares (+1987.4%) to their portfolio in Q4 2025, for an estimated $449,572,740
- WELLINGTON MANAGEMENT GROUP LLP added 15,393,753 shares (+37.0%) to their portfolio in Q4 2025, for an estimated $431,179,021
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KEURIG DR PEPPER Congressional Stock Trading
Members of Congress have traded $KDP stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $KDP stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 09/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
KEURIG DR PEPPER Analyst Ratings
Wall Street analysts have issued reports on $KDP in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 10/28/2025
- BNP Paribas issued a "Underperform" rating on 09/22/2025
- Piper Sandler issued a "Overweight" rating on 09/17/2025
- Citigroup issued a "Buy" rating on 09/16/2025
To track analyst ratings and price targets for KEURIG DR PEPPER, check out Quiver Quantitative's $KDP forecast page.
KEURIG DR PEPPER Price Targets
Multiple analysts have issued price targets for $KDP recently. We have seen 10 analysts offer price targets for $KDP in the last 6 months, with a median target of $34.0.
Here are some recent targets:
- Kaumil Gajrawala from Jefferies set a target price of $32.0 on 12/17/2025
- Michael Lavery from Piper Sandler set a target price of $38.0 on 12/15/2025
- Chris Carey from Wells Fargo set a target price of $35.0 on 10/28/2025
- Lauren Lieberman from Barclays set a target price of $30.0 on 10/28/2025
- Andrea Teixeira from JP Morgan set a target price of $36.0 on 10/20/2025
- Peter Galbo from B of A Securities set a target price of $33.0 on 10/08/2025
- Bonnie Herzog from Goldman Sachs set a target price of $29.0 on 10/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
